about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
0.82
0.06
(7.89%)
951.9K
XNAS Volume
High vol.+gain this week
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..